PTSM: Pharmaceutical Technology Sourcing and Management, Oct 12, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Oct 12, 2010
Sourcing
Collaborative Innovation in Sourcing and Procurement
By Patricia Van Arnum
Gregg Brandyberry, CEO of Wildfire Commerce, senior advisor of AT Kearney procurement and analytic solutions, and former vice-president of procurement of global systems and operations for GlaxoSmithKline, discusses collaborative innovation in customer-supplier relations.
Outsourcing
R&D Mash-ups
By Jim Miller
Changing demands in drug development lead to new service combinations and models.
CSR and Sustainability Forum
World Leaders Map Strategy for Achieving Millennium Development Goals
By Patricia Van Arnum
World leaders gathered at the United Nations last month to review the progress and map out a strategy for achieving the Millennium Development Goals.
Roche Gains Top Spot in Sustainability Among Pharmaceutical Companies
By Patricia Van Arnum
An annual analysis rates the performance of pharmaceutical and biotechnology companies in corporate sustainability.
CSR and Sustainability Forum
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here